2025-2031 Global Linaclotide Capsules Industry Research & Trends Analysis Report- YH Research

日本语 | 中文

Home > Reports >Pharma & Healthcare > 2025-2031 Global Linaclotide Capsules Industry Research & Trends Analysis Report

2025-2031 Global Linaclotide Capsules Industry Research & Trends Analysis Report

Publication Date: 2025-12-09
Report Id: 2469536
Industry: Pharma & Healthcare
Report Page: 111
Chart: 111

PDF Download

Publication Date: 2025-12-09
Report Id: 2469536
Industry: Pharma & Healthcare
Report Page: 111
Chart: 111

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Linaclotide Capsules Definition
1.2 Global Linaclotide Capsules Market Size and Forecast
1.2.1 By Revenue, Global Linaclotide Capsules Market Size, 2020-2031
1.2.2 By Sales Volume, Global Linaclotide Capsules Market Size, 2020-2031
1.2.3 Global Linaclotide Capsules Price Trend, 2020-2031
1.3 China Linaclotide Capsules Market Size and Forecast
1.3.1 By Revenue, China Linaclotide Capsules Market Size, 2020-2031
1.3.2 By Sales Volume, China Linaclotide Capsules Market Size, 2020-2031
1.3.3 China Linaclotide Capsules Price Trend, 2020-2031
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Linaclotide Capsules Share in Global Market, 2020-2031
1.4.2 By Sales Volume, China Linaclotide Capsules Share in Global Market, 2020-2031
1.4.3 Linaclotide Capsules Market Size: China VS Global, 2020-2031
1.5 Linaclotide Capsules Market Dynamics
1.5.1 Linaclotide Capsules Market Drivers
1.5.2 Linaclotide Capsules Market Restraints
1.5.3 Linaclotide Capsules Industry Trends
1.5.4 Linaclotide Capsules Industry Policy

2 Global Competitive Landscape by Company
2.1 Global Linaclotide Capsules Revenue by Company, 2020-2025
2.2 Global Linaclotide Capsules Sales Volume by Company, 2020-2025
2.3 Global Linaclotide Capsules Price by Company, 2020-2025
2.4 Global Linaclotide Capsules Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Linaclotide Capsules Concentration Ratio
2.6 Global Linaclotide Capsules Mergers & Acquisitions, Expansion Plans
2.7 Global Linaclotide Capsules Manufacturers Product Type

3 China Competitive Landscape by Company
3.1 China Linaclotide Capsules Revenue by Company, 2020-2025
3.2 China Linaclotide Capsules Sales Volume by Company, 2020-2025
3.3 China Linaclotide Capsules Linaclotide Capsules Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.4 China Linaclotide Capsules Market, Sales Percentage of Local Players VS Foreign Players (2020-2025)
3.5 Chinese Local Players, Linaclotide Capsules Domestic VS Export
3.6 China Market, Linaclotide Capsules Import & Export
3.6.1 China Market, Linaclotide Capsules Import & Export, 2020-2031
3.6.2 China Linaclotide Capsules Import & Export Trends
3.6.3 Main Sources of China Linaclotide Capsules Import
3.6.4 Export Destination of China Linaclotide Capsules

4 Linaclotide Capsules Production by Region
4.1 Global Linaclotide Capsules Capacity, Production and Capacity Utilization, 2020-2031
4.2 Global Geographic Distribution of Linaclotide Capsules Manufacturers
4.3 Global Major Manufacturers, Linaclotide Capsules Capacity Expansion and Future Plans
4.4 Global Linaclotide Capsules Capacity by Region
4.5 Global Linaclotide Capsules Production by Region
4.5.1 Global Linaclotide Capsules Production & Forecast by Region, 2020 VS 2024 VS 2031
4.5.2 Global Linaclotide Capsules Production by Region, 2020-2025
4.5.3 Global Linaclotide Capsules Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Linaclotide Capsules Industry Chain
5.2 Linaclotide Capsules Upstream Analysis
5.2.1 Linaclotide Capsules Core Raw Materials
5.2.2 Main Manufacturers of Linaclotide Capsules Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Linaclotide Capsules Production Mode
5.6 Linaclotide Capsules Procurement Model
5.7 Linaclotide Capsules Industry Sales Model and Sales Channels
5.7.1 Linaclotide Capsules Sales Model
5.7.2 Linaclotide Capsules Typical Distributors

6 Sights by Type
6.1 Linaclotide Capsules Classification by Type
6.1.1 72μg
6.1.2 145μg
6.1.3 290μg
6.2 by Type, Global Linaclotide Capsules Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Linaclotide Capsules Revenue, 2020-2031
6.4 by Type, Global Linaclotide Capsules Sales Volume, 2020-2031
6.5 by Type, Global Linaclotide Capsules Price, 2020-2031

7 Sights by Production Model
7.1 Linaclotide Capsules Classification by Production Model
7.1.1 In-House Manufactured API
7.1.2 CDMO Contract Production API
7.1.3 Others
7.2 by Production Model, Global Linaclotide Capsules Market Size & CAGR, 2020 VS 2024 VS 2031
7.3 by Production Model, Global Linaclotide Capsules Revenue, 2020-2031
7.4 by Production Model, Global Linaclotide Capsules Sales Volume, 2020-2031
7.5 by Production Model, Global Linaclotide Capsules Price, 2020-2031

8 Sights by Therapeutic Area
8.1 Linaclotide Capsules Classification by Therapeutic Area
8.1.1 Chronic Constipation Treatment
8.1.2 IBS-C Treatment
8.1.3 Others
8.2 by Therapeutic Area, Global Linaclotide Capsules Market Size & CAGR, 2020 VS 2024 VS 2031
8.3 by Therapeutic Area, Global Linaclotide Capsules Revenue, 2020-2031
8.4 by Therapeutic Area, Global Linaclotide Capsules Sales Volume, 2020-2031
8.5 by Therapeutic Area, Global Linaclotide Capsules Price, 2020-2031

9 Sights by Application
9.1 Linaclotide Capsules Segment by Application
9.1.1 Hospitals
9.1.2 Clinics
9.1.3 Others
9.2 by Application, Global Linaclotide Capsules Market Size & CAGR, 2020 VS 2024 VS 2031
9.3 by Application, Global Linaclotide Capsules Revenue, 2020-2031
9.4 by Application, Global Linaclotide Capsules Sales Volume, 2020-2031
9.5 by Application, Global Linaclotide Capsules Price, 2020-2031

10 Sales Sights by Region
10.1 By Region, Global Linaclotide Capsules Market Size, 2020 VS 2024 VS 2031
10.2 By Region, Global Linaclotide Capsules Revenue, 2020-2031
10.3 By Region, Global Linaclotide Capsules Sales Volume, 2020-2031
10.4 North America
10.4.1 North America Linaclotide Capsules Market Size & Forecasts, 2020-2031
10.4.2 By Country, North America Linaclotide Capsules Market Size Market Share
10.5 Europe
10.5.1 Europe Linaclotide Capsules Market Size & Forecasts, 2020-2031
10.5.2 By Country, Europe Linaclotide Capsules Market Size Market Share
10.6 Asia Pacific
10.6.1 Asia Pacific Linaclotide Capsules Market Size & Forecasts, 2020-2031
10.6.2 By Country/Region, Asia Pacific Linaclotide Capsules Market Size Market Share
10.7 South America
10.7.1 South AmericaLinaclotide Capsules Market Size & Forecasts, 2020-2031
10.7.2 By Country, South America Linaclotide Capsules Market Size Market Share
10.8 Middle East & Africa

11 Sales Sights by Country Level
11.1 By Country, Global Linaclotide Capsules Market Size & CAGR，2020 VS 2024 VS 2031
11.2 By Country, Global Linaclotide Capsules Revenue, 2020-2031
11.3 By Country, Global Linaclotide Capsules Sales Volume, 2020-2031
11.4 United States
11.4.1 United States Linaclotide Capsules Market Size, 2020-2031
11.4.2 By Company, United States Linaclotide Capsules Sales Volume Market Share, 2024
11.4.3 by Type, United States Linaclotide Capsules Market Size, Share, 2024 VS 2031
11.4.4 by Application, United States Linaclotide Capsules Market Size, Share, 2024 VS 2031
11.5 Europe
11.5.1 Europe Linaclotide Capsules Market Size, 2020-2031
11.5.2 By Company, Europe Linaclotide Capsules Sales Volume Market Share, 2024
11.5.3 by Type, Europe Linaclotide Capsules Market Size, Share, 2024 VS 2031
11.5.4 by Application, Europe Linaclotide Capsules Market Size, Share, 2024 VS 2031
11.6 China
11.6.1 China Linaclotide Capsules Market Size, 2020-2031
11.6.2 By Company, China Linaclotide Capsules Sales Volume Market Share, 2024
11.6.3 by Type, China Linaclotide Capsules Market Size, Share, 2024 VS 2031
11.6.4 by Application, China Linaclotide Capsules Market Size, Share, 2024 VS 2031
11.7 Japan
11.7.1 Japan Linaclotide Capsules Market Size, 2020-2031
11.7.2 By Company, Japan Linaclotide Capsules Market Share, 2024
11.7.3 by Type, Japan Linaclotide Capsules Market Size, Share, 2024 VS 2031
11.7.4 by Application, Japan Linaclotide Capsules Market Size, Share, 2024 VS 2031
11.8 South Korea
11.8.1 South Korea Linaclotide Capsules Market Size, 2020-2031
11.8.2 By Company, South Korea Linaclotide Capsules Market Share, 2024
11.8.3 by Type, South Korea Linaclotide Capsules Market Size, Share, 2024 VS 2031
11.8.4 by Application, South Korea Linaclotide Capsules Market Size, Share, 2024 VS 2031
11.9 Southeast Asia
11.9.1 Southeast Asia Linaclotide Capsules Market Size, 2020-2031
11.9.2 By Company, Southeast Asia Linaclotide Capsules Market Share, 2024
11.9.3 by Type, Southeast Asia Linaclotide Capsules Market Size, Share, 2024 VS 2031
11.9.4 by Application, Southeast Asia Linaclotide Capsules Market Size, Share, 2024 VS 2031
11.10 India
11.10.1 India Linaclotide Capsules Market Size, 2020-2031
11.10.2 By Company, India Linaclotide Capsules Market Share, 2024
11.10.3 by Type, India Linaclotide Capsules Market Size, Share, 2024 VS 2031
11.10.4 by Application, India Linaclotide Capsules Market Size, Share, 2024 VS 2031
11.11 Middle East & Africa
11.11.1 Middle East & Africa Linaclotide Capsules Market Size, 2020-2031
11.11.2 By Company, Middle East & Africa Linaclotide Capsules Market Share, 2024
11.11.3 by Type, Middle East & Africa Linaclotide Capsules Market Size, Share, 2024 VS 2031
11.11.4 by Application, Middle East & Africa Linaclotide Capsules Market Size, Share, 2024 VS 2031

12 Manufacturers Profile
12.1 AbbVie
12.1.1 AbbVie Company Information, Head Office, Market Area, and Industry Position
12.1.2 AbbVie Linaclotide Capsules Models, Specifications, and Application
12.1.3 AbbVie Linaclotide Capsules Sales Volume, Revenue, Price and Gross Margin, 2020-2025
12.1.4 AbbVie Company Profile and Main Business
12.1.5 AbbVie Recent Developments
12.2 Astellas
12.2.1 Astellas Company Information, Head Office, Market Area, and Industry Position
12.2.2 Astellas Linaclotide Capsules Models, Specifications, and Application
12.2.3 Astellas Linaclotide Capsules Sales Volume, Revenue, Price and Gross Margin, 2020-2025
12.2.4 Astellas Company Profile and Main Business
12.2.5 Astellas Recent Developments
12.3 AstraZeneca
12.3.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position
12.3.2 AstraZeneca Linaclotide Capsules Models, Specifications, and Application
12.3.3 AstraZeneca Linaclotide Capsules Sales Volume, Revenue, Price and Gross Margin, 2020-2025
12.3.4 AstraZeneca Company Profile and Main Business
12.3.5 AstraZeneca Recent Developments
12.4 Mylan Pharmaceuticals
12.4.1 Mylan Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
12.4.2 Mylan Pharmaceuticals Linaclotide Capsules Models, Specifications, and Application
12.4.3 Mylan Pharmaceuticals Linaclotide Capsules Sales Volume, Revenue, Price and Gross Margin, 2020-2025
12.4.4 Mylan Pharmaceuticals Company Profile and Main Business
12.4.5 Mylan Pharmaceuticals Recent Developments
12.5 Aurobindo Pharma
12.5.1 Aurobindo Pharma Company Information, Head Office, Market Area, and Industry Position
12.5.2 Aurobindo Pharma Linaclotide Capsules Models, Specifications, and Application
12.5.3 Aurobindo Pharma Linaclotide Capsules Sales Volume, Revenue, Price and Gross Margin, 2020-2025
12.5.4 Aurobindo Pharma Company Profile and Main Business
12.5.5 Aurobindo Pharma Recent Developments

13 Conclusion

14 Appendix
14.1 Research Methodology
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Market Estimation Model
14.4 Disclaimer

According to YH Research, the global market for Linaclotide Capsules should grow from US$ 3024 million in 2024 to US$ 4394 million by 2031, with a CAGR of 5.5% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Linaclotide Capsules

According to YH Research, the global market for Linaclotide Capsules should grow from US$ 3024 million in 2024 to US$ 4394 million by 2031, with a CAGR of 5.5% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Linaclotide Capsules, indicated for chronic constipation and IBS-C, rely on Linaclotide API, pharmaceutical excipients (including microcrystalline cellulose, lactose, and coating agents), capsule shells, blister and secondary packaging materials, as well as QC and batch-release consumables as their upstream inputs. Downstream customers encompass global prescription drug manufacturers, hospital procurement channels, retail pharmacy networks, commercial insurance reimbursement systems, cross-border and direct-to-consumer distribution channels, and clinical research as well as real-world safety evaluation institutions. In 2024, global production capacity is estimated at approximately 850 million capsules, with sales volume around 790 million capsules; the average ex-factory price per capsule is approximately USD 3.6, and the industry maintains an average gross margin of 60%–70%, offering stable commercial returns and growth potential in patient penetration. Driven by global population aging, increasing awareness of functional gastrointestinal disorders, evolving prescription practices in gastroenterology, and long-term therapy demand, the global market for Linaclotide Capsules continues to expand. However, it faces constraints from reimbursement negotiations, generic entry, regional price variations, and increasing regulatory compliance costs, shifting market competition from single sales-driven dynamics toward comprehensive strategies including brand lifecycle management, indication expansion, and formulation innovation.

Linaclotide Capsules hold a significant position in the global functional gastrointestinal disorder treatment market, supported by consistent clinical efficacy and high patient adherence, earning long-term recognition from prescription drug manufacturers and healthcare channels. The current market landscape shows steady penetration in mature markets while educational and promotional efforts in emerging regions are gradually increasing, forming a stable global prescription demand foundation. The robust production and supply chain—including high-purity API supply, excipients and formulation control, quality testing, and batch release—ensures reliability in both commercial and clinical applications.

Future development trends indicate that the Linaclotide Capsule market will continue to benefit from population aging, increased awareness of functional gastrointestinal disorders, growth in long-term therapy demand, and optimized gastroenterology prescription structures. As global healthcare systems place greater focus on chronic constipation and IBS-C treatment, market education, patient management programs, and long-term prescription support policies will further expand the potential patient base, while formulation optimization and dosage form extensions will provide differentiated competitive advantages for manufacturers.

Market drivers include sustained clinical demand, high patient adherence, brand recognition, mature distribution channels, commercial collaboration models, and the ability of formulation companies to capture higher margins through lifecycle management, indication expansion, and channel optimization. At the same time, stricter regulatory requirements, changes in reimbursement and pricing policies, generic drug entry, regional price differences, and rising quality and compliance costs represent significant constraints on market growth. Manufacturers must balance cost control, regulatory compliance, global market coverage, and long-term brand strategy to maintain competitive strength.

Overall, the global market performance of Linaclotide Capsules is stable, with rational and sustainable growth. With formulation improvements, enhanced market education, expanding patient bases, and brand extension strategies, market potential continues to be realized. Profitability and market share in high-end segments are expected to improve steadily, although manufacturers must remain vigilant regarding generic competition and policy-related risks that could affect growth dynamics.

This report aims to provide a comprehensive study of the global market for Linaclotide Capsules. 
Report Highlights:
(1) Global Linaclotide Capsules market size (sales volume & revenue), history data from 2020-2025, and forecast data from 2026 to 2031.

(2) Global Linaclotide Capsules market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(3) China Linaclotide Capsules market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(4) Global Linaclotide Capsules segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Linaclotide Capsules segment by Type, and by Application, and regional segment by Type, and by Application.

(6) Global major production regions of Linaclotide Capsules, capacity, production and trends.

(7) Linaclotide Capsules industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
    72μg
    145μg
    290μg

Market segment by Production Model, covers
    In-House Manufactured API
    CDMO Contract Production API
    Others

Market segment by Therapeutic Area, covers
    Chronic Constipation Treatment
    IBS-C Treatment
    Others

Market segment by Application, can be divided into
    Hospitals
    Clinics
    Others

Market segment by players, this report covers
    AbbVie
    Astellas
    AstraZeneca
    Mylan Pharmaceuticals
    Aurobindo Pharma